Pharma Tech Industries Earns Top Carbon Disclosure Project Score for Sustainability Efforts

• Pharma Tech Industries received top marks in the Carbon Disclosure Project (CDP) evaluation, scoring 11 “B”s in key climate-related categories.

• The company’s commitment to environmental sustainability and transparency was recognised, reinforcing its dedication to eco-conscious practices in manufacturing.

Pharma Tech Industries, a global provider of contract manufacturing and packaging solutions for pharmaceutical, OTC, and nutritional products, has earned exceptional scores in the latest Carbon Disclosure Project (CDP) evaluation. The company secured 11 “B” grades across CDP’s 13 climate-related categories, a notable achievement in the environmental sustainability sector. This recognition highlights Pharma Tech Industries’ ongoing commitment to reducing its environmental impact.

The CDP, a globally respected non-profit, assesses how well organisations manage their environmental impact. For Pharma Tech Industries, excelling in categories like energy usage, environmental policies, and emissions reduction initiatives has solidified its reputation as a leader in sustainability. The company’s efforts align with the growing trend of businesses focusing on transparency in their environmental practices.

“We challenge ourselves to integrate sustainability considerations into each of our processes, always with an eye toward aligning with our clients’ corporate sustainability goals while maximizing the quality of our products and customer service,” said Darrin Schellin, CEO of Pharma Tech Industries.

The company, based in Georgia and Missouri, continues to be a trusted provider of powder-based products and custom packaging services, offering solutions such as sachets, tablets, and medical devices. Pharma Tech Industries’ outstanding performance in the CDP evaluation is a testament to its long-standing dedication to environmental responsibility and continuous improvement in sustainability.